Clinical trial Recruiting at 3 sites Interventional Ages 50 and up

Assessing the safety and performance of a new intraocular lens for cataract surgery

Official title: Multicentric Clinical Investigation to Determine Safety and Efficacy of a Hydrophobic Acrylic Multifocal Intraocular Lens

Run by Cutting Edge SAS · NCT06446817 · Data updated 2026-11-12

This study is testing a new type of lens for cataract surgery to see if it improves vision better than a standard lens for people aged 50 and older.

More Cataract trials

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment57 (estimated)
SponsorCutting Edge SAS
Industry-sponsored
Locations3 sites (Marseille and 2 other locations)
StatusRecruiting
StartedDecember 19, 2024
Main results expectedSeptember 2028
Study endsDecember 2028
Registry record updatedMay 26, 2026
Trial IDNCT06446817 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 50 or older with bilateral cataracts who have not undergone previous refractive surgery.

Probably not a fit

Patients with significant ocular comorbidities or those requiring secondary surgical interventions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical investigation aims to evaluate the safety and performance of the LuxHighAdd intraocular lens (IOL) when implanted bilaterally in patients with cataracts. Participants will be compared to those receiving the LuxGood monofocal lens to determine the effectiveness of the new multifocal lens. The study will involve patients aged 50 and over who meet specific eligibility criteria, ensuring a controlled environment for accurate results. The primary focus is on the outcomes related to vision improvement and safety post-implantation.

Why it matters

Potential benefit: If successful, this study could provide patients with improved vision outcomes following cataract surgery through the use of a new multifocal lens.

How similar studies have gone: Other studies have shown promising results with multifocal intraocular lenses, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject aged 50 or over on the day of inclusion, presenting a bilateral cataract, qualified for bilateral implantation
* No ocular comorbidity possibly affecting the study results
* Fit within the available IOL diopter range
* Have had no previous refractive surgery
* Regular corneal astigmatism ≤1.0 dioptres
* Clear intraocular media other than cataract
* Availability, willingness and sufficient cognitive awareness to comply with examination procedures
* Ability to attend all study follow-ups
* Signed informed consent.

Exclusion Criteria:

* Ocular surface disease potentially affecting study results
* Pre-existing ocular pathology or history of pathology potentially affecting the study results
* Acute or chronic disease or illness that would increase risk or confound study results
* Subjects who may be reasonably expected to require a secondary surgical intervention at any time during the investigation (other than YAG capsulotomy)
* Axial lengths and keratometry such as the IOL spherical power is not in the range of 16 to 26 D
* Instability of keratometry or biometry measurements
* Traumatic cataract
* Amblyopia
* History of ocular trauma or any prior ocular surgery including refractive procedures
* Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens
* Pupil abnormalities
* Systemic or ocular medication that could modify pupil dynamics
* Expected complicated surgery or complicated surgery
* Concurrent participation in another drug or device investigation

Where it's running

  • Centre d'Ophtalmologie des Dr Rozot et associés
    Marseille, France
    Recruiting
  • Clinique Honoré Cave
    Montauban, France
    Recruiting
  • Hôpital Fondation Adolphe de Rothschild
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.